Ex-FDA chief testifies against J&J in Risperdal liability case


Johnson & Johnson ($JNJ) knew as early as 2001 that its antipsychotic drug Risperdal could cause boys to grow breasts, former FDA chief David Kessler testified in a Philadelphia court Wednesday. That’s 5 years before the company added a warning about the side effect to the drug’s official label…

A different kind of torture

Jeb ‘Put Me Through Hell’


After the hearing was over, outside the courthouse in Tallahassee, Michael Schiavo angrily asked reporters about the whereabouts of Bush.

“If this was so important to the governor, where is he?” he said. He then got personal, referring to Bush’s daughter, Noelle, who had been arrested in 2002 after trying to buy Xanax with a forged prescription and then relapsed in rehab. “I can remember you sitting here in front of every one of these reporters with tears in your eyes when your daughter had problems,” he raged, “and you asked for privacy and you got it. Why aren’t you giving me my privacy and Terri her privacy?”

In June, the medical examiner released Terri Schiavo’s autopsy, which confirmed what the judges had ruled for years based on the testimony from doctors concerning her prognosis. Her limbs had atrophied, and her hands had clenched into claws, and her brain had started to disappear. It weighed barely more than a pound and a third, less than half the size it would have been under normal circumstances. “No remaining discernible neurons,” the autopsy said. She couldn’t see. She couldn’t feel, not even pain. Forty-one years after her birth, 15 years after her collapse, Terri Schiavo was literally a shell of who she had been…

FCC changes broadband regulations to require almost 6X faster speeds

Minimum downloading speed raised from 4 to 25 Mbps


And as of today, the number of Americans who lack broadband access is vastly greater: 53 percent of rural Americans and 8 percent of urban Americans currently lack access to 25-3 Internet speeds, according to an FCC report…

And here in Albuquerque, I’m one of the 53%.

Organtica vs. New MexiCann


It appears that New MexiCann is being allowed to expand its operation before those like Organtica, who have been waiting for years for the Department of Health to add producers. And what do you know, New MexiCann snatched up the well-to-do area of Taos — which was Organtica’s first choice for a new location.  Considering the DOH’s tight reigns on this program, it is extremely doubtful that the agency will allow another dispensary to be licensed in Taos.

I don’t think it’s fair for the DOH to give economic deference to New MexiCann, no matter how much power and influence this producer has — but now I totally understand everything that Len Goodman has been saying recently, since he cozied up to the DOH.

Mr. Goodman has strong connections to Americans for Safe Access, a group that I believe is working against marijuana legalization, while putting on a front that it’s working for patients.  Of course, both of these parties are reaping the economic benefits of the medical cannabis industry, while producers like Organtica are made to sit on the sidelines.

I freely admit to a negative bias against New MexiCann due to my past experiences with this dispensary, so maybe I’m looking at this situation in the wrong way.  There are hundreds of patients who are more than happy with New MexiCann, so maybe it’s a good idea for this producer to expand (not only to Taos, but other areas too).  And I guess good ideas don’t have to be fair and impartial…

So, what’s your NarxCheck score?


11/11/2014, Appriss® acquires NARxCHECK™ from the Natl Assoc Boards of Pharmacy Foundation

The technology supports practitioners by accessing patient prescription information from prescription drug monitoring programs (PMP), analyzing the data, and providing a risk-based score to assist practitioners in their health care decision-making…

A computer deciding who gets pain medication and who doesn’t?  Sounds fair, right?

Click to access russell.pdf

November 14, 2012

National Association of Boards of Pharmacy, DEA 2012 National Conference

Pharmacies and the DEA, sittin’ in a tree, k-i-s-s-i-n-g… and making bundles of money while doing so.  Does that make the NABP a whore?  Yes, yes I think it does.